great promise as a therapeutic approach that directly addresses the underlying genetic basis 23 of disease. In its most precise form, genome editing can use cellular homology-directed repair 24 (HDR) pathways to insert information from an exogenously supplied DNA repair template 25 (donor) directly into a targeted genomic location. Unfortunately, particularly for long 26 insertions, toxicity and delivery considerations associated with repair template DNA can 27 limit the number of donor molecules available to the HDR machinery, thus limiting HDR 28 efficacy. Here, we explore modifications to both double-stranded and single-stranded repair 29 template DNAs and describe simple 5′ end modifications that consistently and dramatically 30 increase donor potency and HDR efficacy across cell types and species. 31
Nuclease-directed genome editing is a powerful tool for investigating physiology and has 22
great promise as a therapeutic approach that directly addresses the underlying genetic basis 23 of disease. In its most precise form, genome editing can use cellular homology-directed repair 24 (HDR) pathways to insert information from an exogenously supplied DNA repair template 25 (donor) directly into a targeted genomic location. Unfortunately, particularly for long 26 insertions, toxicity and delivery considerations associated with repair template DNA can 27 limit the number of donor molecules available to the HDR machinery, thus limiting HDR 28 efficacy. Here, we explore modifications to both double-stranded and single-stranded repair 29 template DNAs and describe simple 5′ end modifications that consistently and dramatically 30 increase donor potency and HDR efficacy across cell types and species. 31
In the nematode worm C. elegans, efficient genome editing can be achieved by direct 32 injection of editing enzyme guide-RNA ribonucleoprotein (RNP) complexes into the syncytial 33 ovary 1 . Such injections afford simultaneous access of the editing machinery to hundreds of meiotic 34 germ nuclei within a common cytoplasm (Supplementary Fig. 1a ). In the worm germline, high 35 rates of HDR are readily achieved using short (under ~200 nucleotide [nt]), single-stranded 36 oligodeoxynucleotide (ssODN) donor templates that permit insertions of up to ~150 nt in length 2, 37 3 4 . However, HDR is less efficient by 1-2 orders of magnitude when longer, double-stranded DNA 38 (dsDNA) templates are used as donors 4 .
39
Longer repair templates are likely at a disadvantage for multiple reasons. First, toxicity 40 associated with high concentrations of DNA limits the safe injectable amount of a ~1kb dsDNA 41 donor to roughly ~10-fold fewer molecules than is commonly used for a 200 nt ssODN donor [2] [3] [4] [5] . 42
Second, long dsDNA donor molecules may not readily transit across the nuclear envelope into the 43 post-mitotic germ-nuclei, further reducing the effective concentration at the site of repair. We 44 hypothesized that the disparity in availability of ssODN and dsDNA donor molecules inside germ 45 nuclei could account for the differences in observed HDR efficiencies. To increase potency of long 46 dsDNA donors we set out to attach an SV40 peptide containing the core nuclear localization signal 47 (NLS) to the donor molecule, reasoning that the modification might promote nuclear uptake and 48 retention. Previous studies using mammalian cell cultures demonstrated that the addition of an 49 NLS enhances nuclear uptake of plasmid DNA following transfection 6 . To attach an NLS to a 50 long donor DNA, we first conjugated 15-nucleotide 2′-O-methyl (2′OMe) RNA adapters via a tri-51 or tetraethylene glycol (TEG) linkage to the 5′ ends of two target-locus specific synthetic ~20-52 nucleotide DNA oligonucleotides. The DNA sequences in these molecules serve as PCR primers 53 to amplify the donor from plasmid containing the homology arms and green fluorescent protein 54 (GFP) sequence for in-frame insertion into the target gene of interest (Fig. 1a) . In addition, we 55 synthesized an NLS peptide linked to a peptide nucleic acid (PNA) complementary to the 15nt 56 2′OMe-RNA adapter. Attachment of the NLS to the donor was then achieved by simply annealing 57 the PNA::NLS molecules to the 2′OMe-RNA adapters on the ends of the PCR product. 58
To test these modified donors, we first attempted to insert GFP into the csr-1 locus (see 59
Methods for details). We employed a co-CRISPR assay 7, 8 , to measure HDR efficacy. For this 60 assay we chose a CRISPR RNP designed to generate indels in the easily scored dpy-10 locus. HDR 61 efficacy was scored as a fraction of F1 dpy-10 mutant animals that properly express GFP::CSR-1, 62 which forms bright peri-nuclear foci in germ cells (Supplementary Fig. 1b) . To increase assay 63 sensitivity, we chose an initial donor DNA concentration of 10 ng/µl (~35-fold less than previously 64 recommended) 2 . With unmodified dsDNA donors, this donor concentration yielded only 0.92% 65 GFP insertions (Fig. 1b) . Strikingly, however, under otherwise identical injection conditions, this 66 same dsDNA donor modified at both 5′ ends with 2′OMe-RNA::TEG annealed to PNA::NLS 67 positive cells, compared to 22% GFP+ cells obtained with the same amount of unmodified donor 91 (Fig. 2a) . This gain of GFP+ cells was accompanied by a corresponding reduction in mCherry+ 92 cells (Fig. 2b) . As expected, with reduced donor amount the HDR efficacy declined for all donor 93 types, and the number of GFP+ cells also declined at donor amounts over 2 pmol (Fig. 2a, b) . The 94 maximum HDR efficacy for unmodified donors (25% GFP+ cells) was achieved at 1.6 pmol. 95
Notably, the 2′OMe-RNA::TEG modified donors matched this efficacy of 25% at less than 0.4 96 pmol, illustrating that the modified donor is approximately 4-fold more potent (Fig. 2a) . Although 97 less dramatic than the 30-fold efficacy increase observed in worms (which appear to have a much 98 lower basal HDR efficacy), we consistently observed more than 2-fold increases in HDR efficacy 99 using this mammalian cell culture system. Interestingly, however, the addition of PNA::NLS or 100 PNA alone to the 2′OMe-RNA::TEG end-modified donor provided no additional increase in HDR 101 efficacy in cell culture (Fig. 2a, Supplementary Fig 2) . 102
We next used the TLR assay to define the features of the 2′OMe-RNA::TEG adapter that 103 promote HDR at the optimal 1.2 pmol donor amount (Fig. 2c, d) . Interestingly, we found that 104 donors modified with either the 2′OMe-RNA alone or with TEG alone consistently boosted HDR 105 efficiencies (Fig. 2c) . Moreover, even donors with TEG modification at the 5′ end of only one of 106 the two strands provided a significant boost in HDR efficacy (Supplementary Fig. 3a) . Finally, 107 different lengths of PEG (4, 6, 9 or 12 ethylene glycol repeats) showed similar efficacy 108 (Supplementary Fig. 4a ). In all cases we observed a corresponding decline in mCherry+, 109 imprecisely edited, cells (Fig. 2d, Supplementary Fig. 3b, 4b) . 110
To explore the utility of end-modified donors for repair at other genomic locations, we 111 generated donors and guides to integrate full-length eGFP at the endogenous GAPDH and 112 TOMM20 loci in HEK293T cells. The GAPDH donor was designed to integrate IRES-eGFP in the 113 3′-UTR of the GAPDH locus, whereas the TOMM20 donor was designed to tag the C-terminus of 114 the mitochondrial protein TOM20 10, 11 . By measuring the fraction of cells expressing eGFP by 115 flow cytometry, we found that the TEG, 2′OMe-RNA or 2′OMe-RNA::TEG modifications 116 consistently increased the fraction of eGFP cells (by up to 4-fold) when compared to unmodified 117 dsDNA donor (Fig. 2e, f) . Again, in these loci, as in the TLR assay (Fig. 2c) , we noted that the 118 presence of TEG was necessary for maximal HDR and that TEG alone performed better than 119 2′OMe-RNA alone. As expected, in all cases, precise insertion of eGFP was Cas9-dependent. 120
We next tested modified donors in cell types that are typically more resistant to HDR than 121 are the HEK293T cells used in the above studies. To do this we generated 2′OMe-RNA::TEG 122 donors and Cas9 RNPs designed to target the insertion of eGFP at the TOMM20 locus in hTERT-123 immortalized human foreskin fibroblasts (HFFs) and at the Gapdh locus in Chinese hamster ovary 124 (CHO) cells. Although the overall efficiencies of HDR were lower than those observed in 125 HEK293T cells, the use of modified donors led to a 2.3-fold and 6-fold increase in HDR in HFF 126 and CHO cells respectively (Fig. 2g, h ). 127
The experiments described thus far employed dsDNA donors that are easy to generate by 128 PCR; however, single stranded DNA (ssDNA) donors have become widely used in many HDR 129 editing protocols. We therefore tested end modifications to ~800 nt long ssDNA donors generated 130 by transcription and reverse transcription of PCR products. As observed for dsDNA donors, we 131
found that the addition of a 2′OMe-RNA::TEG tail to a long ssDNA donor elicited a consistent 132 and significant boost in HDR efficacy over unmodified ssDNA donors (with corresponding 133 reductions in imprecise repair) across a range of concentrations in the TLR assay (Fig. 2i,  134 Supplementary Fig. 5a ). Efficacy of modified ssDNA donor was 2.3 times higher than 135 unmodified donor at 1 pmol and peaked to 22.5% at 6 pmol (versus 15.9% for unmodified). 136 Furthermore, the maximal efficacy of the plain donor (16% at 8 pmol) could be achieved at less 137 than 2 pmol of 2′OMe-RNA::TEG donor, again highlighting the improved potency of the modified 138
donors. 139
The highest reported yields of HDR in both cultured mammalian cells and C. elegans have 140 been achieved using short (£ 200 nt), synthetic ssODN donors delivered at high concentrations 2-141 4, 12 . To test 5′ modified ssODNs for HDR efficacy we used the sensitive GFP-to-BFP conversion 142 assay in K562 cells (Fig. 2j) . At first, we were surprised to find that 5′ modified ssODNs gave no 143 increase in HDR efficacy, ~30%, when tested at 10pmol, an amount at which unmodified ssODNs 144 gave a peak efficacy of >45% HDR (Fig. 2j) . In order to fully investigate the relative potency of 145 modified ssODNs we decided to explore a broader range of concentrations. Our studies revealed 146 that both modified and unmodified donors exhibited similar maximal levels of BFP positive cells 147 but differed greatly in their donor amount dependence. Strikingly, the end modified ssODNs 148 achieved maximal efficacy at amounts 10-fold lower than unmodified donor (Fig.2j) . Interestingly 149 TEG-modified ssODN donors showed dose-limiting toxicity that scaled with their increased HDR 150 potency ( Fig. 2j) -suggesting that the mechanisms of toxicity and improved HDR efficacy may 151 be related (see further discussion below). The increased potency of HDR was observed with 152 concurrent reductions in imprecise editing as measured by the frequency of GFP(-) and BFP(-) 153 cells ( Supplementary Fig. 5b) . 154
To explore how 3′ modifications affect HDR efficacy we added either internal 155 phosphorothioate (PS) or terminal 2′OMe-RNA and/or TEG modifications to the 3′ ends of 156 ssODNs. Interestingly, 2′OMe-RNA and/or TEG modifications on the 3′ terminal hydroxyl group 157 -modifications that would prevent these molecules from priming DNA synthesis or undergoing 158
ligation -led to a significant decrease in HDR efficacy relative to 5′ modification alone (Fig. 2k , 159 Supplementary Fig. 6 ). In contrast, modification of the 3′ internal phosphate linkages as PS 160 modifications, which do not block the terminal hydroxyl group, did not impede HDR. The 161 differences between the effects of terminal (2′OMe-RNA and/or TEG) and non-terminal (PS) 3′ 162 modifications on HDR efficacy of the 5′-terminally modified donors suggest that the mechanism 163 of HDR improvement requires the availability of a 3′-OH group. Unlike the modifications 164 conjugated to the 5′ terminus, at 0.5 pmol of donor, internal PS modifications at the 5′-end did not 165 improve HDR efficacy compared to the unmodified donor (Supplementary Fig. 6 ). 166
Here we have employed the simple approach of chemically modifying the repair template 167 to promote HDR. We initially hypothesized that exploiting active nuclear import would increase 168 donor potency. In C. elegans, the addition of complementary PNA and PNA::NLS to 2′OMe-169 RNA::TEG donors led to improved HDR efficacy. In contrast, these adducts did not improve 170 efficacy in mammalian cells over use of the 2′OMe-RNA::TEG donor itself. One potential 171 explanation for this interesting difference is that the site of injection in C. elegans is a post-mitotic 172 ovary, as compared with rapidly dividing mammalian cells. Thus, the putative role of PNA::NLS 173 in getting donor past the nuclear envelope should be further explored in other systems involving 174 post-mitotic or slowly-dividing cell types. The finding that annealing PNA and PNA-peptide 175 fusions to the 2′OMe-RNA stimulates HDR in C. elegans raises the question of what other nucleic 176 acid or nucleic acid-like adapters might also stimulate HDR. We have yet to scratch the surface of 177 potential chemistries to explore with this modular system. 178
We were surprised to find that the 5′ addition of either TEG or 2′OMe-RNA alone was 179 sufficient to dramatically improve HDR potency. Oligonucleotides bearing these simple, easy to 180 synthesize chemistries have already proven to be safe and well tolerated in other clinical 181 applications 13 . These modifications increased the potency of dsDNA, ssDNA and ssODN donors, 182 allowing efficient editing at significantly lower amounts. We find it intriguing that long DNA 183 donors exhibited both increased potency and maximal efficacy when modified, while short 184 ssODNs exhibited increased potency over a broader range of donor amounts without an increase 185 in the maximal levels of templated repair. This difference requires further study but could be 186 repair template molecules. However, it is unlikely that merely blocking end joining explains the 205 improved efficacy, as modifications to the 3′ ends, which should also block end-to-end ligation, 206 were unhelpful. Taken together our findings suggest that a combination of blocking the 5′ end 207 while leaving a 3′ OH end, perhaps to prime repair synthesis, are both important. 208
We initiated these investigations to explore why long DNA donors were so much less 209 along with other modifications, in Supplementary Fig. 6 . All data points represent a mean of at 262 least three independent replicates and all error bars represent standard deviation. P-values were 263 calculated using either one-way or two-way ANOVA and in all cases end-modified donors were 264 compared to the unmodified donor unless indicated otherwise (Tukey's multiple comparisons test; 265 ****P < 0.0001; ***P < 0.001; **P < 0.01; *P< 0.05; ns-not significant dsDNA Donor generation. Donor template sequences with the homology arms and the desired insert for knock-in (eg: gfp), were generated by PCR. PCR products were cloned into ZeroBlunt TOPO vector (Invitrogen, #450245) and plasmids were purified using Macherey-Nagel midi-prep kits (cat# 740412.50). Using the purified plasmids as templates and PEGylated oligos as primers, donor sequences were PCR amplified with iProof (Bio-Rad,1725302, C. elegans) or Phusion polymerase (NEB, #M0530S, mammalian). Before use in C. elegans microinjections, the resulting PEGylated PCR products were excised from 0.8-1% TAE agarose gel and purified using spincolumns (Omega, #D2501-02). For use in mammalian cells, the PEGylated PCR products were purified using spin columns (Qiagen, # 28104). PCR conditions were optimized for each primer set with a gradient for the annealing temperature [1) 98°C for 1:00 min,2) 98°C for 15 sec, 3) 50°C
to 64°C for 30 sec (choose optimal), 4) 72°C for 1:00 min (34 cycles), 5) 72°C for 5:00 min, 6)
4°C forever].
Single Strand DNA donor generation. Long single stranded DNA donors were prepared using the protocol described by Li et al
1
. Briefly, the donor template containing the T7 promoter was amplified using standard PCR and purified using SPRI magnetic beads (Core Genomics). T7 in vitro transcription was performed using the HiScribe T7 High Yield RNA Synthesis kit (NEB) and the RNA was purified using the SPRI magnetic beads. Finally, the ssDNA donor was synthesized by TGIRT™-III (InGex) based reverse transcription using the synthesized RNA as a template and a TEG-modified or unmodified DNA primer. We then performed base-treatment to remove RNA.
The donor was again purified using SPRI beads. C. elegans GFP tagging strategy. In C. elegans, we aimed to insert the entire coding sequence of Green Fluorescent Protein (GFP) immediately after the ATG start codon of csr-1 and glh-1 genes.
For csr-1, we used a two-step CRISPR protocol, such that the same exact reagents could be used to fuse any gene to a large DNA sequence, without requiring synthesis of modified primers for every locus (such as GFP or mCherry ~900 bp). Briefly, we employed Cas9-RNP complexes and single stranded DNA (ssODN) donor oligo (as described in 2 to knock-in FLAG (x3)::Glycine(x3)
linker::TEV tag. Starting strain that is homozygous for 3XFLAG::GlyGlyGly::TEV::CSR-1 allele was used to knock-in gfp sequence between flag and glycine-linker. We used a crRNA (CTATAAAGACGATGACGATA NGG) with PAM site in the glycine-linker and donor DNA with arms homologous to 35 bp of 3xflag and 30 bp of 3xglycine-linker::tev flanking the gfp sequence. Once conditions were optimized with universal 2-step system, endogenous glh-1 locus was targeted for gfp insertion directly using glh-1 guide and 35bp homology arms.
Expression and purification of SpyCas9. The pMCSG7 vector containing the 6xHis-tagged 3xNLS SpyCas9 was a gift from Scot Wolfe at UMass Medical School. This construct was transformed into the Rosetta 2 DE3 strain of E. coli for protein production. Expression and purification of SpyCas9 was performed as described previously 5 . Briefly, cells were grown at 37°C to OD600 of 0.6, at which point 1 mM IPTG (Sigma) was added and the temperature was lowered to 18°C. Cells were grown overnight and harvested by centrifugation at 4,000 g. The 
